Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
[anti-HA]
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
[Akt3]
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
[LA]
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
[JAK2]
Homo sapiens solute carrier family 7 (amino acid transporter light chain, L system), member 5 (SLC7A5)
Synonyms:
4F2LC; CD98; D16S469E; E16; hLAT1; LAT1; MPE16
Immunogen
Peptide with sequence C-RHRKPELERPIKVN, from the internal region of the protein sequence according to NP_003477.4.
Buffer
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.Aliquot and store at -20C. Minimize freezing and thawing.
Clone Name
Isotype
Species Reactivity
Human
Concentration
0.5ug/ul
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. (Protein A or G Sepharose)
Guaranteed Application *
WB
Suggested Dilutions
WB: 1-3ug/ml
Background
Related Pathway
Hemostasis
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
(0.3ug/ml) staining of Human Spleen lysate (35ug protein in RIPA buffer) with (B) and without (A) blocking with the immunising peptide. Primary incubation was 1 hour. Detected by chemiluminescence.
Researchers who bought this antibody have also purchased:
